FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.
about
FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
FOXC1 overexpression is a mark ...... triple-negative breast cancer.
@ast
FOXC1 overexpression is a mark ...... triple-negative breast cancer.
@en
type
label
FOXC1 overexpression is a mark ...... triple-negative breast cancer.
@ast
FOXC1 overexpression is a mark ...... triple-negative breast cancer.
@en
prefLabel
FOXC1 overexpression is a mark ...... triple-negative breast cancer.
@ast
FOXC1 overexpression is a mark ...... triple-negative breast cancer.
@en
P2093
P2860
P1476
FOXC1 overexpression is a mark ...... triple-negative breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1007/S00280-017-3319-4
P50
P577
2017-05-10T00:00:00Z
P6179
1085459511